+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hospital Acquired Infection"

Phage Therapy - Global Strategic Business Report - Product Thumbnail Image

Phage Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 149 Pages
  • Global
From
From
Candidiasis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 474 Pages
  • Global
From
Antimicrobial Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Antimicrobial Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 494 Pages
  • Global
From
Caspofungin - Global Strategic Business Report - Product Thumbnail Image

Caspofungin - Global Strategic Business Report

  • Report
  • October 2025
  • 279 Pages
  • Global
From
Peptide Antibiotics - Global Strategic Business Report - Product Thumbnail Image

Peptide Antibiotics - Global Strategic Business Report

  • Report
  • October 2025
  • 381 Pages
  • Global
From
Carbapenem - Global Strategic Business Report - Product Thumbnail Image

Carbapenem - Global Strategic Business Report

  • Report
  • October 2025
  • 383 Pages
  • Global
From
From
Aminoglycosides - Global Strategic Business Report - Product Thumbnail Image

Aminoglycosides - Global Strategic Business Report

  • Report
  • October 2025
  • 402 Pages
  • Global
From
From
From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 183 Pages
  • Global
From
From
From
Vancomycin - Global Strategic Business Report - Product Thumbnail Image

Vancomycin - Global Strategic Business Report

  • Report
  • October 2025
  • 78 Pages
  • Global
From
Antibacterial Drugs - Global Strategic Business Report - Product Thumbnail Image

Antibacterial Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 244 Pages
  • Global
From
Antibiotics - Global Strategic Business Report - Product Thumbnail Image

Antibiotics - Global Strategic Business Report

  • Report
  • October 2025
  • 266 Pages
  • Global
From
Infection Control Surveillance Solutions Market Report 2025 - Product Thumbnail Image

Infection Control Surveillance Solutions Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Report 2025 - Product Thumbnail Image

Antimicrobial Resistance Diagnostics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Blood Stream Infection Testing Market Report 2025 - Product Thumbnail Image

Blood Stream Infection Testing Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Loading Indicator

The Hospital Acquired Infection (HAI) market is a subset of the Infectious Diseases Drugs market. HAIs are infections that occur in a hospital setting, and can be caused by a variety of bacteria, viruses, and fungi. These infections can be difficult to treat, as they are often resistant to antibiotics. As such, HAI drugs are designed to target specific pathogens, and are often used in combination with other treatments. The HAI market is driven by the increasing prevalence of antibiotic-resistant infections, as well as the need for more effective treatments. Additionally, the rising number of hospitalizations due to chronic illnesses has also contributed to the growth of the market. Some of the major players in the HAI market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, and Johnson & Johnson. These companies are actively developing new drugs and treatments to address the growing prevalence of HAIs. Show Less Read more